Compliance of procalcitonin-guided antibiotic therapy in adult infectious patients in China: a multicenter real-world retrospective study - Summary - MDSpire

Compliance of procalcitonin-guided antibiotic therapy in adult infectious patients in China: a multicenter real-world retrospective study

  • By

  • Xiaojing Li

  • Anke Shi

  • Yu Wang

  • Xiaolan Chen

  • Guoqiang Zhang

  • Shengtao Yan

  • May 18, 2026

  • 0 min

Share

Objective:

To evaluate adherence to procalcitonin (PCT)-guided antibiotic management and its impact on patient outcomes in adult infectious disease patients in China, addressing real-world adherence issues.

Key Findings:
  • Among 195 patients, 52.3% met PCT criteria for antibiotic discontinuation.
  • Lower mortality rate in compliant cases (13.7% vs. 28.0%, p = 0.023).
  • Early discontinuation within 24 hours was associated with shorter EICU stays (7 vs. 18 days) and lower antibiotic durations (6 vs. 14 days).
  • No increase in mortality was observed with early discontinuation.
Interpretation:

Adherence to PCT-guided algorithms for antibiotic management is low in China, but timely discontinuation is associated with improved outcomes without increased mortality, highlighting the need for better implementation in clinical practice.

Limitations:
  • Retrospective design may introduce bias.
  • Single-center data may limit generalizability.
  • Potential confounding factors affecting results were not fully addressed.
Conclusion:

Further prospective studies are needed to confirm the benefits of PCT-guided antibiotic management in clinical practice, particularly focusing on adherence strategies.

Original Source(s)

Related Content